trending Market Intelligence /marketintelligence/en/news-insights/trending/fmzfwaeeryrz7u4yxqwd7q2 content esgSubNav
In This List

VTv Therapeutics secures $2.5M investment

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


VTv Therapeutics secures $2.5M investment

High Point, N.C.-based vTv Therapeutics Inc. received a $2.5 million investment from MacAndrews & Forbes Group LLC.

The drug developer exercised its right — part of a July 30 agreement — to have the investor acquire 1,879,699 of its class A common shares at $1.33 each.

VTv Therapeutics discovers, develops and sells orally administered small molecule drug candidates.